| Net loss arising during the development stage | |
| Share-based compensation | 737K |
| Fair value of derivative liabilities in excess of proceeds | |
| Gain on adjustment to fair value of derivative liabilities | |
| Financing costs | |
| Depreciation | |
| Prepaid expenses and other current assets | -910K |
| Accounts payable | -330K |
| Accrued liabilities | -2.01M |
| Amounts due to related party | |
| Net cash used in operating activities | |
| Purchases of property and equipment | -2K |
| Net cash used in investing activities | |
| Net proceeds from issuance of common stock | 4.21M |
| Net proceeds from issuance of preferred stock | |
| Financing costs | |
| Net cash provided by financing activities | |
| Net (decrease)/increase in cash and cash equivalents | 2.95M |
| Cash and cash equivalents at beginning of the period | 10.84M |
| Cash and cash equivalents at end of the period | 13.79M |